Evolution of a Treatment Paradigm for Renal Cell Carcinoma: Targeting Multiple Signaling Pathways
 
The objective of the Pocket Guide is to provide oncologists with current data on the rapidly evolving changes occurring in the management of renal cell carcinoma (RCC). The goal of the Companion Audio CD Clinical Roundtable is to provide oncologists with expert commentary on clinical practice issues in the management of RCC. After completing these activities, participants should be better able to: list the most appropriate treatments available in the management of RCC; discuss the results from the latest studies on the use of multi-kinase inhibitors in the treatment of RCC; describe the mechanism of action and list the indications for use of new targeted agents for unresectable and recurrent RCC; and apply the latest NCCN guidelines in the management of patients with RCC.

We gratefully acknowledge Pfizer Inc for its generous support of this educational activity.

Please contact Continuing Education Alliance at inquiries@cealliance.org for questions regarding this activity.

Release date: November 15, 2007  
Expiration: November 15, 2008

Download a PDF of the
Pocket Guide



Access the Pocket Guide Evaluation Form and Self Assessment Questions


Listen to the Companion Audio CD Clinical Roundtable


Access the Clinical Roundtable Evaluation Form and Self Assessment Questions